CS logo
small CS logo
Kliniken Maria Hilf GmbH

Monchengladbach, Germany
Krankenhaus in Mönchengladbach, Nordrhein-Westfalen

About Kliniken Maria Hilf GmbH


Das ehemalige Krankenhaus Maria Hilf steht in Mönchengladbach, Sandradstraße 43–47. Die hier bis Mitte 2018 beheimateten Fachkliniken wurden im Rahmen der Standortzusammenlegung zu Ende des 5. Bauabschnittes im Krankenhaus St. Franziskus in die dort neuen Gebäude an der Viersener Str. 450 verlegt.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
German CLL Study Group
7
German High-Grade Non-Hodgkin's Lymphoma Study Group
5
Bayer
4
Hoffmann-La Roche
3
Ipsen
3
Pfizer
3
Biotronik SE & Co. KG
2
Boehringer Ingelheim
2
Celgene
2
Incyte Corporation
2
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
2
Total Rows: 43

Clinical Trials at Kliniken Maria Hilf GmbH


During the past decade, Kliniken Maria Hilf GmbH conducted 34 clinical trials. In the 10-year time frame, 34 clinical trials started and 18 clinical trials were completed, i.e. on average, 52.9% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 9 clinical trials were completed. i.e. 75% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years33555555447733221111112244442222Started TrialsCompleted Trails2015201620172018201920202021202202468
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Chemotherapy and Biological Therapy With or Without Bone Marrow or Peripheral Stem Cell Transplant in Treating Patients With Chronic Myelogenous Leukemia
1997-07-01
Unknown status
1,000
Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma
2001-01-01
2010-08-05
Completed
1,506
Combination Chemotherapy Followed By Radiation Therapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma
2002-04-01
2006-12-05
Completed
392
Imatinib Mesylate With or Without Interferon Alfa or Cytarabine Compared With Interferon Alfa Followed by Donor Stem Cell Transplant in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia
2002-06-01
2017-03-31
Completed
1,551
BBR 2778 for Relapsed, Aggressive Non-Hodgkin's Lymphoma (NHL)
2004-07-01
2010-07-01
Completed
140
Bendamustine and Rituximab in Treating Patients With Previously Untreated or Relapsed Chronic Lymphocytic Leukemia
2005-11-01
2011-03-01
Completed
195
Cyclophosphamide and Total Body Irradiation in Treating Patients Who Are Undergoing an Autologous Peripheral Stem Cell Transplant For Chronic Lymphocytic Leukemia
1998-01-01
2012-04-01
Completed
169
Rituximab and Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With B-Cell Non-Hodgkin's Lymphoma
2005-11-01
2018-02-01
Completed
700

Rows per page:

1–69 of 69

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Kliniken Maria Hilf GmbH" #1 sponsor was "German CLL Study Group" with 7 trials, followed by "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 5 trials sponsored, "Bayer" with 4 trials sponsored, "Hoffmann-La Roche" with 3 trials sponsored and "Ipsen" with 3 trials sponsored. Other sponsors include 42 different institutions and companies that sponsored additional 43 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Kliniken Maria Hilf GmbH" #1 collaborator was "AstraZeneca" with 3 trials as a collaborator, "Cancer Trials Ireland" with 2 trials as a collaborator, "Merck Sharp & Dohme LLC" with 2 trials as a collaborator, "Nordic CLL Study Group (NCLLSG)" with 2 trials as a collaborator and "Trium Analysis Online GmbH" with 2 trials as a collaborator. Other collaborators include 43 different institutions and companies that were collaborators in the rest 53 trials.
Created with Highcharts 11.1.0Top Leading SponsorsGerman CLL Study Group: 7German CLL Study Group: 7German High-GradeNon-Hodgkin'sLymphoma StudyGroup: 5German High-GradeNon-Hodgkin'sLymphoma StudyGroup: 5Bayer: 4Bayer: 4Hoffmann-La Roche: 3Hoffmann-La Roche: 3Ipsen: 3Ipsen: 3Pfizer: 3Pfizer: 3Biotronik SE & Co. KG: 2Biotronik SE & Co. KG: 2Boehringer Ingelheim: 2Boehringer Ingelheim: 2Celgene: 2Celgene: 2Incyte Corporation: 2Incyte Corporation: 2

Created with Highcharts 11.1.0Top CollaboratorsAstraZeneca: 3AstraZeneca: 3Cancer Trials Ireland: 2Cancer Trials Ireland: 2Merck Sharp & Dohme LLC: 2Merck Sharp & Dohme LLC: 2Nordic CLL Study Group(NCLLSG): 2Nordic CLL Study Group(NCLLSG): 2Trium Analysis Online GmbH: 2Trium Analysis Online GmbH: 2AbbVie: 1AbbVie: 1BARMER GEK Germany: 1BARMER GEK Germany: 1Baxter HealthcareCorporation: 1Baxter HealthcareCorporation: 1Bayer: 1Bayer: 1Bristol-Myers Squibb: 1Bristol-Myers Squibb: 1

Clinical Trials Conditions at Kliniken Maria Hilf GmbH


According to Clinical.Site data, the most researched conditions in "Kliniken Maria Hilf GmbH" are "Atrial Fibrillation" (6 trials), "Lymphoma" (6 trials), "Chronic Lymphocytic Leukemia" (5 trials), "Colorectal Cancer" (3 trials) and "Heart Failure" (3 trials). Many other conditions were trialed in "Kliniken Maria Hilf GmbH" in a lesser frequency.

Clinical Trials Intervention Types at Kliniken Maria Hilf GmbH


Most popular intervention types in "Kliniken Maria Hilf GmbH" are "Drug" (48 trials), "Biological" (16 trials), "Radiation" (9 trials), "Other" (7 trials) and "Procedure" (7 trials). Other intervention types were less common.
The name of intervention was led by "Rituximab" (7 trials), "cyclophosphamide" (7 trials), "Placebo" (6 trials), "radiation therapy" (6 trials) and "Obinutuzumab" (5 trials). Other intervention names were less common.

Clinical Trials Genders at Kliniken Maria Hilf GmbH


The vast majority of trials in "Kliniken Maria Hilf GmbH" are 69 trials for "All" genders.

Clinical Trials Status at Kliniken Maria Hilf GmbH


Currently, there are NaN active trials in "Kliniken Maria Hilf GmbH". undefined are not yet recruiting, 11 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 39 completed trials in Kliniken Maria Hilf GmbH, undefined suspended trials, and 5 terminated clinical trials to date.
Out of the total trials that were conducted in Kliniken Maria Hilf GmbH, 0 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 37 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 5 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 37Phase 3: 37Phase 2: 15Phase 2: 15Not Applicable: 5Not Applicable: 5Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 39Completed: 39Recruiting: 11Recruiting: 11Active, not recruiting: 10Active, not recruiting: 10Terminated: 5Terminated: 5Unknown status: 4Unknown status: 4

Departments of Kliniken Maria Hilf GmbH


Kliniken Maria Hilf GmbH has several departments that took part in Clinical trials: "Kliniken Maria Hilf GmbH Klinik für Hämatologie, Onkologie und Gastroenterologie" - 2 trials
Departments List
Total Rows: 1